IN8BIO, INC. Operating Cash Flow
IN8BIO, INC. (INAB) reported Operating Cash Flow of -$8.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- IN8BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.75M.
- IN8BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.95M.
- IN8BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.14M.
- IN8BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.52M.
- IN8BIO, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$12.71M.
- IN8BIO, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$24.15M.
- IN8BIO, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$23.34M.
- IN8BIO, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$24.12M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.69M 10-Q · filed 2026-08-06 | -$10.83M derived: sum of 3 quarters · filed 2026-08-06 | -$14.36M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$4.95M 10-Q · filed 2026-05-07 | -$7.09M derived: sum of 2 quarters · filed 2026-05-07 | -$10.61M derived: sum of 3 quarters · filed 2026-05-07 | -$14.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$5.66M derived: sum of 2 quarters · filed 2026-03-12 | -$9.59M derived: sum of 3 quarters · filed 2026-08-06 | -$12.71M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$7.45M derived: sum of 2 quarters · filed 2026-08-06 | -$10.57M 10-Q · filed 2025-11-06 | -$14.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.05M 10-Q · filed 2026-08-06 | -$11.08M derived: sum of 3 quarters · filed 2026-08-06 | -$17.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$3.12M 10-Q · filed 2026-05-07 | -$7.15M derived: sum of 2 quarters · filed 2026-05-07 | -$13.26M derived: sum of 3 quarters · filed 2026-05-07 | -$19.35M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$10.14M derived: sum of 2 quarters · filed 2026-03-12 | -$16.23M derived: sum of 3 quarters · filed 2026-03-12 | -$24.15M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$12.20M derived: sum of 2 quarters · filed 2025-11-06 | -$20.12M 10-Q · filed 2025-11-06 | -$24.97M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$6.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$14.01M 10-Q · filed 2025-08-07 | -$18.86M derived: sum of 3 quarters · filed 2025-08-07 | -$24.57M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$7.92M 10-Q · filed 2025-05-07 | -$12.77M derived: sum of 2 quarters · filed 2025-05-07 | -$18.48M derived: sum of 3 quarters · filed 2025-05-07 | -$23.82M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$10.56M derived: sum of 2 quarters · filed 2025-03-13 | -$15.90M derived: sum of 3 quarters · filed 2025-03-13 | -$23.34M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$5.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$11.05M derived: sum of 2 quarters · filed 2024-11-12 | -$18.49M 10-Q · filed 2024-11-12 | -$26.44M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$5.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$12.78M 10-Q · filed 2024-08-08 | -$20.73M derived: sum of 3 quarters · filed 2024-08-08 | -$26.47M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$7.44M 10-Q · filed 2024-05-09 | -$15.39M derived: sum of 2 quarters · filed 2024-05-09 | -$21.13M derived: sum of 3 quarters · filed 2024-05-09 | -$27.00M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$13.69M derived: sum of 2 quarters · filed 2024-03-14 | -$19.56M derived: sum of 3 quarters · filed 2024-03-14 | -$24.12M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$11.61M derived: sum of 2 quarters · filed 2023-11-09 | -$16.17M 10-Q · filed 2023-11-09 | -$18.35M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$10.43M 10-Q · filed 2023-08-10 | -$12.61M derived: sum of 3 quarters · filed 2023-08-10 | -$18.97M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$4.56M 10-Q · filed 2023-05-12 | -$6.74M derived: sum of 2 quarters · filed 2023-05-12 | -$13.10M derived: sum of 3 quarters · filed 2023-05-12 | -$15.56M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$8.54M derived: sum of 2 quarters · filed 2023-03-30 | -$11.00M derived: sum of 3 quarters · filed 2023-03-30 | -$13.51M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$8.83M derived: sum of 2 quarters · filed 2022-11-10 | -$11.33M 10-Q · filed 2022-11-10 | -$13.06M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$4.97M 10-Q · filed 2022-08-12 | -$6.69M derived: sum of 3 quarters · filed 2022-08-12 | -$8.82M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$2.51M 10-Q · filed 2022-05-12 | -$4.23M derived: sum of 2 quarters · filed 2022-05-12 | -$6.36M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$3.85M derived: sum of 2 quarters · filed 2022-03-17 | -$7.13M 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$5.41M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$3.28M 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |